Concepedia

Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1−42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease

Nazia Siddiqui, Javed Ali, Suhel Parvez, Saima Zameer, Abul Kalam Najmi, Mohd Akhtar

Neuropharmacology · 2021 · 59 citations · 51 references

DOI

Concepts

References

51

A new and rapid colorimetric determination of acetylcholinesterase activity

George L. Ellman, K. Diane Courtney, Valentino Andres et al. · Biochemical Pharmacology · 1961 · 26.6K citations

, , +4

World Alzheimer Report 2015.The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends.

Martin Prince, Anders Wimo, Maëlenn Guerchet et al. · HAL (Le Centre pour la Communication Scientifique Directe) · 2015 · 2.3K citations · Full text

, , +16

Mechanisms of lipid peroxide formation in animal tissues

E.D. Wills · Biochemical Journal · 1966 · 1.3K citations · Full text

Alzheimer's Disease is Type 3 Diabetes—Evidence Reviewed

Suzanne M. de la Monte, Jack R. Wands · Journal of Diabetes Science and Technology · 2008 · 1.1K citations · Full text

, , +20

An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers

Theresa R. Bomfim, Letícia Forny‐Germano, Luciana B. Sathler et al. · Journal of Clinical Investigation · 2012 · 812 citations · Full text

, , +28